TNF Pharmaceuticals, Valuation
| TNFA Stock | 1.36 0.11 7.48% |
Today, the company appears to be overvalued. TNF Pharmaceuticals, has a current Real Value of USD1.14 per share. The regular price of the company is USD1.36. Our model measures the value of TNF Pharmaceuticals, from examining the company fundamentals such as number of shares shorted of 279.28 K, and Return On Equity of -2.98 as well as evaluating its technical indicators and probability of bankruptcy. Key fundamental drivers impacting TNF Pharmaceuticals,'s valuation include:
Price Book 0.4357 | Enterprise Value -9.5 M |
Overvalued
Today
Please note that TNF Pharmaceuticals,'s price fluctuation is abnormally volatile at this time. Calculation of the real value of TNF Pharmaceuticals, is based on 3 months time horizon. Increasing TNF Pharmaceuticals,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since TNF Pharmaceuticals, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of TNF Stock. However, TNF Pharmaceuticals,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.36 | Real 1.14 | Hype 1.27 |
The real value of TNF Stock, also known as its intrinsic value, is the underlying worth of TNF Pharmaceuticals, Company, which is reflected in its stock price. It is based on TNF Pharmaceuticals,'s financial performance, growth prospects, management team, or industry conditions. The intrinsic value of TNF Pharmaceuticals,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of TNF Pharmaceuticals, helps investors to forecast how TNF stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of TNF Pharmaceuticals, more accurately as focusing exclusively on TNF Pharmaceuticals,'s fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use TNF Pharmaceuticals,'s intrinsic value based on its ongoing forecasts of TNF Pharmaceuticals,'s financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against TNF Pharmaceuticals,'s closest peers. If more than one evaluation category is relevant for TNF Pharmaceuticals, we suggest using both methods to arrive at a better estimate.
TNF Pharmaceuticals, Cash |
|
TNF Valuation Trend
Comparing TNF Pharmaceuticals,'s enterprise value against its market capitalization is a good way to estimate the value of TNF Pharmaceuticals, uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
TNF Pharmaceuticals, Total Value Analysis
TNF Pharmaceuticals, is at this time forecasted to have valuation of (9.48 M) with market capitalization of 3.13 M, debt of 48.87 K, and cash on hands of . The negative valuation of TNF Pharmaceuticals, may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the TNF Pharmaceuticals, fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(9.48 M) | 3.13 M | 48.87 K |
TNF Pharmaceuticals, Asset Utilization
One of the ways to look at asset utilization of TNF is to check how much profit was generated for every dollar of assets it reports. TNF Pharmaceuticals, has a negative utilization of assets of -0.32 %, losing USD0.003243 for each dollar of assets held by the company. Ineffective asset utilization indicates the company is being less competent with each dollar of assets it has. In other words, asset utilization of TNF Pharmaceuticals, shows how unsuccessful it operates for each dollar spent on its assets.TNF Pharmaceuticals, Ownership Allocation
30% of TNF Pharmaceuticals, outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Therefore, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change.TNF Pharmaceuticals, Profitability Analysis
Net Loss for the year was (4 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates TNF Pharmaceuticals,'s worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in TNF Pharmaceuticals, and how it compares across the competition.
About TNF Pharmaceuticals, Valuation
The stock valuation mechanism determines TNF Pharmaceuticals,'s current worth on a weekly basis. Our valuation model uses a comparative analysis of TNF Pharmaceuticals,. We calculate exposure to TNF Pharmaceuticals,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of TNF Pharmaceuticals,'s related companies.| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (7.49) | (7.12) | |
| Operating Profit Margin | (4.62) | (4.39) | |
| Net Loss | (7.49) | (7.12) | |
| Gross Profit Margin | (0.02) | (0.02) |
TNF Pharmaceuticals, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.5 M |
TNF Pharmaceuticals, Current Valuation Indicators
Valuation refers to the process of determining the present value of TNF Pharmaceuticals, and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value TNF we look at many different elements of the entity such as TNF's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as TNF Pharmaceuticals,, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use TNF Pharmaceuticals,'s valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes TNF Pharmaceuticals,'s worth.Complementary Tools for TNF Stock analysis
When running TNF Pharmaceuticals,'s price analysis, check to measure TNF Pharmaceuticals,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TNF Pharmaceuticals, is operating at the current time. Most of TNF Pharmaceuticals,'s value examination focuses on studying past and present price action to predict the probability of TNF Pharmaceuticals,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TNF Pharmaceuticals,'s price. Additionally, you may evaluate how the addition of TNF Pharmaceuticals, to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |